This article refers to 'Prevention of the development of heart failure with preserved ejection fraction by the phosphodiesterase-5A inhibitor vardenafil in rats with type 2 diabetes,' by C.Matyas et al., published in this issue on pages 326-336.
Phosphodiesterase-5 inhibition in heart failure with preserved ejection fraction : trading therapy for prevention / M. Guazzi, L. van Heerebeek, W.J. Paulus. - In: EUROPEAN JOURNAL OF HEART FAILURE. - ISSN 1388-9842. - 19:3(2017 Mar), pp. 337-339. [10.1002/ejhf.742]
Phosphodiesterase-5 inhibition in heart failure with preserved ejection fraction : trading therapy for prevention
M. Guazzi;
2017
Abstract
This article refers to 'Prevention of the development of heart failure with preserved ejection fraction by the phosphodiesterase-5A inhibitor vardenafil in rats with type 2 diabetes,' by C.Matyas et al., published in this issue on pages 326-336.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Guazzi_et_al-2017-European_Journal_of_Heart_Failure.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
152.24 kB
Formato
Adobe PDF
|
152.24 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
